Dermatofibrosarcoma Protuberans of the Vulva: A Review of the MITO Rare Cancer Group

Author:

Mancari Rosanna1ORCID,Cioffi Raffaella2ORCID,Magazzino Francescapaola3,Attademo Laura4,Sant’angelo Miriam5ORCID,Taccagni Gianluca5,Mangili Giorgia2ORCID,Pignata Sandro6ORCID,Bergamini Alice27

Affiliation:

1. Gynecologic Oncology Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy

2. Department of Obstetrics and Gynaecology, San Raffaele Scientific Institute, 20132 Milan, Italy

3. Complex Operating Unit Ginecologia E Ostetricia, Ospedale Civile Di San Dona’ Di Piave (Venezia), Aulss4 Veneto Orientale, 30027 San Donà di Piave, Italy

4. Oncology Unit, Ospedale del Mare, 80147 Naples, Italy

5. Department of Surgical Pathology, San Raffaele Scientific Institute, 20132 Milan, Italy

6. Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS ‘Fondazione G Pascale’, 80144 Napoli, Italy

7. Faculty of Medicine, Vita-Salute San Raffaele University, 20132 Milan, Italy

Abstract

Background: Vulvar dermatofibrosarcoma protuberans is an extremely rare disease. Its rarity can hamper the quality of treatment; deeper knowledge is necessary to plan appropriate management. The purpose of this review is to analyse the data reported in the literature to obtain evidence regarding appropriate disease management. Methods: We made a systematic search of the literature, including the terms “dermatofibrosarcoma protuberans”, “vulva”, and “vulvar”, alone or in combination. We selected articles published in English from two electronic databases, PubMed and MEDLINE, and we analysed their reference lists to include other potentially relevant studies. Results: We selected 39 articles, with a total of 68 cases reported; they were retrospective case reports and case series. Dermatofibrosarcoma protuberans of the vulva tends towards local recurrence; an early and timely pathological diagnosis, together with an appropriate surgical approach, are of utmost importance to ensure free margins and maximise the curative potential. Conclusions: Even if this is an indolent disease and it generally shows a good prognosis, appropriate management may help in reducing the rate of local recurrences that may hamper patients’ quality of life. Management by a multidisciplinary team is highly recommended.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference43 articles.

1. Clinical Features and Treatment of Dermatofibrosarcoma Protuberans Affecting the Vulva: A Literature Review;Nguyen;Dermatol. Surg.,2017

2. Dermatofibromes progressifs et récidivants ou fibrosarcomes de la peau;Darier;Ann. Dermatol. Syphil.,1924

3. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews;Page;Syst. Rev.,2021

4. Vulvar sarcoma: Clinical implications;Aartsen;Eur. J. Obstet. Gynecol. Reprod. Biol.,1994

5. Dermatofibrosarcoma protuberans of the vulva;Agress;Gynecol. Oncol.,1983

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3